Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1979
Report date:
1979

Materials and methods

Principles of method if other than guideline:
Administration of a single oral dose of the test substance to Sprague-Dawley rats to determine the acute oral toxicity.
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
2-propylheptan-1-ol
EC Number:
233-126-1
EC Name:
2-propylheptan-1-ol
Cas Number:
10042-59-8
Molecular formula:
C10H22O
IUPAC Name:
2-propylheptan-1-ol
Test material form:
liquid
Specific details on test material used for the study:
- Name of test material (as cited in study report): 2-Propylheptanol
- Lot/batch No.: NBP 1282594-A

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: males: 235 - 250 g, females: 235-245 g;

Administration / exposure

Route of administration:
oral: unspecified
Vehicle:
unchanged (no vehicle)
Doses:
5010, 6310, 7940, 10000 mg/kg
No. of animals per sex per dose:
5 animals per dose (males and females)
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
5 400 mg/kg bw
Based on:
test mat.
95% CL:
>= 5 020 - <= 5 780
Mortality:
- 5010 mg/kg bw: males: 0/2, females: 1/3;
- 6310 mg/kg bw: males: 3/3, females: 2/2;
- 7940 mg/kg bw: males: 2/2, females: 3/3;
- 10000 mg/kg bw: males: 3/3, females: 2/2;

Deaths occurred between days 2 - 5
Clinical signs:
other: Increasing weakness, ocular discharge, diarrhea, collapse
Gross pathology:
Decedents: Hemorrhagic lungs, liver discoloration, and acute gastrointestinal inflammation;
Survivors: Viscera appeared normal;

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
According to the results of the study a LD 50 value of 5400 mg/kg bw was established under these test conditions. Therefore no classification according to EU or GHS criteria is required.